{
  "id": 848,
  "text": "Journal of the National Cancer Institute, 116, 857-865.https://doi.org/10.1093/jnci/djad263 [24] Palmer, T., Wallace, L., Pollock, K.G., Cuschieri, K., Robertson, C., Kavanagh, K., et al.(2019) Prevalence of Cervical Disease at Age 20 after Immunisation with Bivalent HPV Vaccine at Age 12 - 13 in Scotland: Retrospective Population Study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Journal of the National Cancer Institute, 116, 857-865.https://doi.org/10.1093/jnci/djad263 [24] Palmer, T., Wallace, L., Pollock, K.G., Cuschieri, K., Robertson, C., Kavanagh, K., et al.(2019) Prevalence of Cervical Disease at Age 20 after Immunisation with Bivalent HPV Vaccine at Age 12 - 13 in Scotland: Retrospective Population Study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据研究显示，在12-13岁时接种二价HPV疫苗的人群中，到20岁时宫颈疾病的患病率显著降低。该疫苗在预防高危型HPV感染（如HPV16和18）引起的宫颈癌前病变方面具有很高的有效性。研究发现，这一年龄段接种疫苗的女性在随后的宫颈癌前病变（CIN2及以上）的发生率明显减少，表明此疫苗在保护年轻女性免受与HPV相关的宫颈疾病方面有显著效果。这进一步支持了早期接种二价HPV疫苗的公共卫生价值，有助于降低年轻女性将来发展为宫颈癌的风险。",
  "query": "基于12-13岁接种二价HPV疫苗的人群，到20岁时宫颈疾病的患病率如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 基于12-13岁接种二价HPV疫苗的人群，到20岁时宫颈疾病的患病率如何？\n\n<reference text>: Journal of the National Cancer Institute, 116, 857-865.https://doi.org/10.1093/jnci/djad263 [24] Palmer, T., Wallace, L., Pollock, K.G., Cuschieri, K., Robertson, C., Kavanagh, K., et al.(2019) Prevalence of Cervical Disease at Age 20 after Immunisation with Bivalent HPV Vaccine at Age 12 - 13 in Scotland: Retrospective Population Study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据研究显示，在12-13岁时接种二价HPV疫苗的人群中，到20岁时宫颈疾病的患病率显著降低。该疫苗在预防高危型HPV感染（如HPV16和18）引起的宫颈癌前病变方面具有很高的有效性。研究发现，这一年龄段接种疫苗的女性在随后的宫颈癌前病变（CIN2及以上）的发生率明显减少，表明此疫苗在保护年轻女性免受与HPV相关的宫颈疾病方面有显著效果。这进一步支持了早期接种二价HPV疫苗的公共卫生价值，有助于降低年轻女性将来发展为宫颈癌的风险。"
}